INTRAOP MEDICAL CORP.

IntraOp Medical Corporation is a California-based manufacturer of electron therapy linear accelerators for cancer treatment. The company specializes in intraoperative radiotherapy (IORT) and non-invasive skin cancer treatment using compact, mobile electron beam devices. The Mobetron, IntraOp's flagship product introduced in 1997, is a self-shielded linear accelerator designed for deployment in operating rooms and outpatient settings. The Mobetron delivers precise electron beam therapy with applications in pancreatic cancer (PDAC), intraoperative radiotherapy, and non-melanoma skin cancer treatment. IntraOp is the first to offer ultra-high dose rate (UHDR) electron therapy approved for FLASH radiotherapy clinical trials, enabling preclinical investigation of FLASH on an established clinical platform. The company reports over 40 Mobetron units installed in leading cancer centers globally. IntraOp employs physicists, engineers, and designers in Silicon Valley to develop and support its radiation therapy systems. The Mobetron platform offers advantages including portability, dynamic pulse modulation, larger clinical volumes, excellent cosmesis for skin cancer cases, and reduced patient recovery times compared to surgical alternatives. Regulatory approvals for FLASH trials and clinical deployment in leading oncology centers establish the company's credibility in the radiation oncology market.